Recurrence of Infantile Hemangiomas Treated with Propranolol

Propranolol for Infantile Hemangiomas

(2011) Lorea Bagazgoitia et al.   PEDIATRIC DERMATOLOGY

Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

(2010) C.H. Storch et al.   BRITISH JOURNAL OF DERMATOLOGY

Expression of components of the renin–angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution

(2010) Tinte Itinteang et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

(2010) Susan J. Bayliss et al.   PEDIATRIC DERMATOLOGY

Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells

(2010) Sylvie Lamy et al.   VASCULAR PHARMACOLOGY

Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

(2009) Leslie P. Lawley et al.   PEDIATRIC DERMATOLOGY

Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

(2009) V. Sans et al.   PEDIATRICS

Infantile Hemangiomas With Unusually Prolonged Growth Phase

(2008) Heather A. Brandling-Bennett et al.   ARCHIVES OF DERMATOLOGY

Propranolol for Severe Hemangiomas of Infancy

(2008) Christine Léauté-Labrèze et al.   NEW ENGLAND JOURNAL OF MEDICINE